NHS administers pioneering CAR-T leukemia therapy to first patient, hailed as sci‑fi

The NHS has funded and begun delivering CAR-T cell therapy for adults with B‑cell ALL, with 28‑year‑old Oscar Murphy receiving the first infusion in Manchester. The personalised “living drug” reprograms a patient’s T‑cells to attack cancer and could extend survival; trial data showed 77% remission and about 15.6 months of added life, with around 50 patients a year expected to benefit across the UK.